Primitive neuroectodermal tumor

Using gene transfer of SV40 large T-antigen in neuronal precursor cells of rats, a brain tumor model was established. The PNETs were histologically indistinguishable from the human counterparts and have been used to identify new genes involved in human brain tumor carcinogenesis.{{cite journal |vauthors=Eibl RH, Kleihues P, Jat PS, Wiestler OD |title=A model for primitive neuroectodermal tumors in transgenic neural transplants harboring the SV40 large T antigen |journal=Am. J. Pathol. |volume=144 |issue=3 |pages=556–64 |date=March 1994 |pmid=8129041 |pmc=1887088 }} The model was used to confirm p53 as one of the genes involved in human medulloblastomas, but since only about 10% of the human tumors showed mutations in that gene, the model can be used to identify the other binding partners of SV40 Large T- antigen, other than p53.{{cite journal |vauthors=Ohgaki H, Eibl RH, Wiestler OD, Yasargil MG, Newcomb EW, Kleihues P |title=p53 mutations in nonastrocytic human brain tumors |journal=Cancer Res. |volume=51 |issue=22 |pages=6202–5 |date=November 1991 |pmid=1933879 |url=http://cancerres.aacrjournals.org/cgi/pmidlookup?view=long&pmid=1933879}}{{additional citation needed|date=July 2021}}

File:Peripheral PNET CD99 200x.jpg

It is classified into two types, based on location in the body: peripheral PNET and CNS PNET.{{citation needed|date=June 2020}}

The peripheral PNET (pPNET) is now thought to be virtually identical to Ewing sarcoma:

"Current evidence indicates that both Ewing's sarcoma and PNET have a similar neural phenotype and, because they share an identical chromosome translocation, they should be viewed as the same tumor, differing only in their degree of neural differentiation. Tumors that demonstrate neural differentiation by light microscopy, immunohistochemistry, or electron microscopy have been traditionally labeled PNETs, and those that are undifferentiated by these analyses have been diagnosed as Ewing's sarcoma."Kumar, Vinay; Fausto, Nelso; Abbas, Abul (2004) Robbins & Cotran Pathologic Basis of Disease (7th ed.). Saunders. Page 1301. {{ISBN|0-7216-0187-1}}.

File:PNET.jpg

{{main|Central nervous system primitive neuroectodermal tumor}}

PNET of the CNS generally refer to supratentorial PNETs.

• In the past medulloblastomas were considered PNETs; however, they are genetically, transcriptionally and clinically distinct. As such, "infratentorial" PNETs are now referred to as medulloblastoma {{Citation needed|date=March 2013}}.
• Pineoblastomas are embryonal tumours originating in the pineal gland and are likely distinct from supratentorial PNETs.

The approach to management of a CNS PNET is first to obtain detailed imaging through MRI, as well as additional scans of the patient's body (X-ray, CT, PET, even bone marrow biopsies) to look for metastasis or other associated malignancies. The tumor will then need to be biopsied to confirm the diagnosis. After the diagnosis of a CNS PNET is confirmed, management includes neoadjuvant chemotherapy and radiation (to reduce tumor size burden), complete surgical resection with confirmed negative margins, and/or additional adjuvant post-surgical chemotherapy. CNS PNET is aggressive and must be managed as so. Palliative care services should also become involved in the patient's care team when the diagnosis is made.

Honrado, Carlo P, and Augustine L Moscatello. Primitive Neuroectodermal Tumors: Background, Epidemiology, Clinical Features, Medscape, 21 Jan. 2021, emedicine.medscape.com/article/855644-overview#a7.

• Medulloblastoma
• Ependymoma
• Ewing family of tumors

{{Reflist}}

{{Medical resources

| DiseasesDB = 31470

| ICD10 =

| ICD9 =

| ICDO = {{ICDO|9473|3}}

| OMIM =

| MedlinePlus =

| eMedicineSubj = ped

| eMedicineTopic = 2589

| eMedicine_mult = {{eMedicine2|neuro|326}}

| MeshID = D018242

}}

{{Nervous tissue tumors}}

{{Osseous and chondromatous tumors}}

Category:Pediatric cancers

Category:Rare cancers

Category:Nervous system neoplasia

Category:Small-blue-round-cell tumors